Mesa Laboratories Inc (MLAB) is a publicly traded Technology sector company. As of May 21, 2026, MLAB trades at $103.59 with a market cap of $559.50M and a P/E ratio of 153.44. MLAB moved +4.26% today. Year to date, MLAB is +19.20%; over the trailing twelve months it is -9.82%. Its 52-week range spans $55.45 to $155.12. Analyst consensus is buy with an average price target of $115.00. Rallies surfaces MLAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Mesa Laboratories Declares $0.16 Quarterly Dividend Payable June 15: Mesa Laboratories’ board declared a $0.16 per share quarterly dividend, payable June 15, 2026, to holders of record at close on May 29, 2026. This marks the company’s ongoing commitment to returning capital through consistent shareholder distributions.
| Metric | Value |
|---|---|
| Price | $103.59 |
| Market Cap | $559.50M |
| P/E Ratio | 153.44 |
| EPS | $0.67 |
| Dividend Yield | 0.16% |
| 52-Week High | $155.12 |
| 52-Week Low | $55.45 |
| Volume | 28 |
| Avg Volume | 0 |
| Revenue (TTM) | $247.54M |
| Net Income | $3.73M |
| Gross Margin | 62.41% |
1 analysts cover MLAB: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $115.00.